Slow responder against methotrexate 50 mg intramuscular in severe psoriatic patients: A case series

• Main Authors: Niken Kusumaningrum (Author), Danar Wicaksono (Author), Dwi Retno Adi Winarni (Author), Yohanes Widodo Wirohadidjojo (Author), Sunardi Radiono (Author)
• Format: Book
• Published: PAGEPress Publications, 2019-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Methotrexate is the drug of choice used on moderate to severe psoriasis. The limited availability of oral tablet methotrexate stimulates the initiation of the protocol therapy 50 mg intramuscular methotrexate weekly in six consecutive weeks for severe psoriasis cases. There were 30 cases treated usi...